Venous Thromboembolism (VTE) — a blood clot that starts in a vein — is the most common preventable cause of hospital death. Per the CDC, 10-30% of people die within one month of VTE diagnosis, and sudden death is the first symptom in 25% of people who have a Pulmonary Embolism (PE). VTE is associated with long-term complications, and one-third of patients with a VTE have a recurrence within 10 years. Pharmacological thromboprophylaxis for VTE is safe, effective and cost-effective. However, there is a gap between the evidence and implementation. Thus many hospitalized patients at risk for VTE are not treated with prophylaxis.
Every patient in the hospital setting is at some form of risk for VTE – and that risk needs assessed through a risk assessment protocol, ideally embedded in an electronic medical record, making it easy for physicians to select the appropriate choice of prophylaxis for medical and surgical patients.
The WSHA VTE Safety Action Bundle is a guide to assist facilities in developing a comprehensive multidisciplinary VTE prevention program. WSHA also provides tools for a multi-disciplinary team to use when ready to engage in a test of change for preventing VTEs.
WSHA provides support for hospitals prepared to launch or re-engage in a safe and effective VTE prevention program. We provide on-site assistance, coaching calls, resources, webinars and surgeon-physician consultation. Contact Meg Kilcup for more information and assistance.